Nachrichten zur Hims & Hers Health Inc. Aktie

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.8% in the afternoon session after a Bank of America…

HIMS insider files Form 144 for 175,661 Class A shares

Hims & Hers (HIMS) filed Form 144 to sell up to 175,661 Class A shares ($11,029,998.25) on or after 10/16/2025…

Why Are Hims & Hers Health Shares Tumbling?

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

Hims & Hers Elevates Technology-Driven Healthcare Accessibility

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, is redefining healthcare delivery through a vertically integrated,…

HIMS News Today: Hims & Hers Health Stock Jumps on Analyst Upgrade

Hims & Hers Health (HIMS) stock surges following an analyst upgrade, highlighting strong prospects in telehealth and market performance.…

Hims & Hers Stocks 150% Surge Is All Fundamentals—No Novo, No Problem - Hims & Hers Health (NYSE:HIMS)

Hims & Hers (HIMS) has seen surprising success, up 150% YTD, driven by their new menopause specialty and refocusing on…

Hims & Hers (HIMS) Soars 16% as Firm On Track to Book $1 Billion Revenues from Women Segment

We recently published 10 Stocks Stealing Today’s Spotlight; 5 on All-Time Highs. Hims & Hers Health, Inc. (NYSE:HIMS) is one…

HIMS News Today: Hims & Hers Health Surges Amidst Q3 Earnings Beat

Hims & Hers Health stock (HIMS) surges following a strong Q3 earnings performance. Discover the details behind the stocks impressive…

Hims & Hers: Ramping Up A New Billion-Dollar Segment (Rating Upgrade) (NYSE:HIMS)

The expansion of Hims & Hers Health, Inc., with a new specialty in Menopause, could spark renewed investor confidence. Click…

Hims & Hers Health expandiert mit Hormonersatzprogrammen

Hims & Hers setzt auf Hormone:  Neue Menopause- und Testosteron-Programme eröffnen Milliardenpotenzial.  Aktie +15 %:  Anleger spekulieren auf weiteres…

Hims & Hers Health (HIMS) Stock: Menopause Platform Launch Sparks Rally

Hims & Hers (HIMS) stock surge 12-16% on menopause care launch. Up 110% YTD but faces FDA scrutiny. Analysts divided…

Whats The Upside Potential For Hims & Hers Stock?

Hims & Hers stock (NYSE: HIMS) surged 16% yesterday after announcing its expansion into menopause and perimenopause treatment—a strategic pivot…

Trending Stocks Today: TSMC, Salesforce, Hims & Hers, and Nestlé Lead Market Buzz

Trending stocks today: TSMC, Salesforce, Hims & Hers, and Nestlé lead market buzz with strong gains and key updates on…

Sell Rating Issued for Hims & Hers Health Due to Limited Market Potential and High-Risk Investment

Analyst Daniel Grosslight from Citi maintained a Sell rating on Hims & Hers Health and keeping the price target at…

Hims & Hers Health: Balancing Growth Enthusiasm with Competitive Challenges

In a report released today, Craig Hettenbach from Morgan Stanley maintained a Hold rating on Hims & Hers Health, with…

Hims & Hers Stock Jumps 9% After Huge Announcement

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…

GoodRx challenges Hims & Hers in D2C prescription drug market

Hims & Hers and GoodRx each moved into new categories of prescription drug sales. Hims and Hers is now offering…

Hims & Hers stock climbs after menopause care launch

Hims & Hers enters menopause care with new telehealth services focused on hormone therapy, aiming to expand its reach in…

Investors Are Buying Hims & Hers Health Stock Following Wednesdays Platform Expansion Announcement - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Wednesday following the companys launch of a new menopause and…

Why Are Hims & Hers Health (HIMS) Shares Soaring Today

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 5.7% in the afternoon session after the company announced the…

Hims & Hers stock faces competition concerns despite positive BofA view By Investing.com

Hims & Hers stock faces competition concerns despite positive BofA view…

Hims & Hers stock faces competition concerns despite positive BofA view By Investing.com

Hims & Hers stock faces competition concerns despite positive BofA view…

Hims & Hers offers menopause, perimenopause treatments

Hims & Hers launches new affordable menopause treatments, including hormone therapies. Read more here.…

Hims & Hers rises after launching menopause and perimenopause treatments

The company will offer pills, patches, and creams and said it expects to add more treatments next year....…

Hims & Hers launches menopause and perimenopause specialty

Hims Hers Health announced the launch of a new specialty in women’s health, offering access to treatment plans for…

Hims & Hers launches perimenopause and menopause care on platform By Investing.com

Hims & Hers launches perimenopause and menopause care on platform…

Hims & Hers stock rises after launching menopause treatment services By Investing.com

Hims & Hers stock rises after launching menopause treatment services…

$1B by 2026: Hims & Hers launches menopause and perimenopause specialty to expand womens health access

Starting Oct 15, 2025, Hims & Hers launched menopause & perimenopause care for 500K+ subscribers; plans may include estradiol or…

Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026

The expansion adds a new specialty to the Hers platform, which already provides access to more than half a million…

Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock?

Motley Fool Press Release.…

Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it…

Hims & Hers: Why I’m Betting On HIMS Heading To $100 (NYSE:HIMS)

HIMS expects revenue growth to rebound, driven by weight loss and new health offerings, aiming for 30%+ growth in 2026.…

Hims & Hers: Why Im Betting On HIMS Heading To $100

…

Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025

Hims Hers Health, Inc. (“Hims Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it…

Hims & Hers Aktie: BofA warnt vor schwachem Quartal - Kursziel bei 28 USD

Charlotte (www.aktiencheck.de) - Hims & Hers-Aktienanalyse von BofA Securities:Die Analysten von BofA Securities haben das Rating "underperform" für die Hims…

Best Healthcare Stocks To Keep An Eye On

UnitedHealth Group, Johnson & Johnson, and Hims & Hers Health are the three Healthcare stocks to watch today, according…

Taking Stock of Hims & Hers Health (HIMS) Valuation After Recent Share Price Dip

Hims & Hers Health (HIMS) shares recently saw a modest dip of about 7% in a single trading session. This…

Callan Family Office LLC Grows Stake in Hims & Hers Health, Inc. $HIMS

Callan Family Office LLC increased its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report)…

Kingswood Wealth Advisors LLC Makes New $241,000 Investment in Hims & Hers Health, Inc. $HIMS

Kingswood Wealth Advisors LLC acquired a new position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in…

Total Wealth Planning & Management Inc. Makes New $593,000 Investment in Hims & Hers Health, Inc. $HIMS

Total Wealth Planning & Management Inc. acquired a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS…

Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know

Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $53.96, signifying a -7.36% move from its prior…